Plus500 appoints Board member Prof. Varda Liberman as new Senior Independent Director

– ISRAEL, Haifa –  Plus500 (LON: PLUS), a global multi‐asset fintech group operating proprietary technology‐based trading platforms, today announced the appointment of current Independent Director Prof. Varda Liberman as Senior Independent Director replacing Anne Grim with immediate effect.

About Plus500

Plus500 is a global multi‐asset fintech group operating proprietary technology‐based trading platforms. Plus500 offers customers a range of trading products, including OTC (“Over‐the‐Counter” products, namely Contracts for Difference), share dealing, as well as futures and options on futures.

The Group retains operating licenses and is regulated in the United Kingdom, Australia, Cyprus, Israel, New Zealand, South Africa, Singapore, Seychelles, the United States, Estonia, Japan, the UAE and the Bahamas and through its OTC product portfolio, offers more than 2,500 different underlying global financial instruments, comprising equities, indices, commodities, options, ETFs, foreign exchange and cryptocurrencies. Customers of the Group can trade its OTC products in more than 50 countries and 30 languages.

Plus500’s trading platforms are accessible from multiple operating systems (Windows, iOS, and Android) and web browsers. Customer care is and has always been integral to Plus500, as such, OTC customers cannot be subject to negative balances. A free demo account is available on an unlimited basis for OTC trading platform users and sophisticated risk management tools are provided free of charge to manage leveraged exposure and stop losses to help customers protect profits while limiting capital losses.

SOURCE: https://www.plus500.com/

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.